Compounds > glutamic acid

glutamic acid and Anxiety Disorders

glutamic acid has been researched along with Anxiety Disorders in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.44)18.7374
1990's0 (0.00)18.2507
2000's22 (53.66)29.6817
2010's15 (36.59)24.3611
2020's3 (7.32)2.80

Authors

AuthorsStudies
Kakanakova, A; Maes, M; Popov, S1
Ballerini, L; Cellot, G; Franceschi Biagioni, A; Kostarelos, K; Secomandi, N1
Bortolotto, ZA; de Carvalho, CR; Formolo, DA; Hoeller, AA; Latini, A; Leal, RB; Lin, K; Linhares, MN; Lopes, MW; Prediger, RD; Sousa, DS; Walz, R; Wolf, P1
Garg, C; Garg, M; Walia, V1
Brechbühl, S; Buchmann, A; Ghisleni, C; Hasler, G; Haynes, M; Müller, ST; Tuura, R1
Adler, CM; Chu, WJ; DelBello, MP; Eliassen, JC; Norris, MM; Phan, KL; Strakowski, SM; Strawn, JR; Weber, WA; Whitsel, RM1
Pitsikas, N1
Lei, Z; Liu, B; Wang, JH1
Cordero, MI; Just, N; Poirier, GL; Sandi, C1
Chen, A; Dedic, N; Deussing, JM; Engelhardt, C; Hartmann, J; Häusl, A; Hoeijmakers, L; Joëls, M; Karst, H; Kertokarijo, M; Labermaier, C; Pöhlmann, ML; Schmidt, MV; Wagner, KV; Westerholz, S1
Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M1
Carroll, FI1
Greengard, P; Heintz, N; Ibanez-Tallon, I; Lieberam, I; Miwa, JM; Nong, Y; Tekinay, AB1
Howells, FM; Russell, VA; Warton, FL1
Drevets, WC; Grillon, C; Hasler, G; Shen, J; van der Veen, JW1
Bidziński, A; Hamed, A; Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Sobolewska, A; Szyndler, J; Taracha, E; Turzyńska, D; Wisłowska-Stanek, A1
Ghalib, K; Heleniak, C; Puliafico, A; Rikhi, P; Rynn, M; Vidair, H1
Blicharska, E; Kasperek, R; Nowak, G; Poleszak, E; Socała, K; Szewczyk, B; Szopa, A; Wlaź, P; Wróbel, A1
Filiou, MD; Frank, E; Gormanns, P; Hambsch, B; Holsboer, F; Kessler, MS; Landgraf, R; Maccarrone, G; Reckow, S; Turck, CW; Zhang, Y1
Bates, BS; Chauder, BA; Conn, PJ; Dawson, ES; Emmitte, KA; Felts, AS; Gregory, KJ; Jadhav, SB; Jones, CK; Kane, AS; Lamb, JP; Lindsley, CW; Meiler, J; Menon, UN; Mueller, R; Niswender, CM; Olsen, CM; Rodriguez, AL; Winder, DG1
Bräuner-Osborne, H; Clausen, RP; Gloriam, D; Harpsøe, K; Jimenez, HN; Kaae, BH; Kvist, T; Madsen, U; Mathiesen, JM; Mølck, C; Nielsen, B; Nielsen, SM; Sauerberg, P; Uberti, MA1
Abdallah, CG; Coplan, JD; Jackowski, A; Mao, X; Mathew, SJ; Sato, JR; Shungu, DC1
Lydiard, RB1
Holden, C1
ZAKRZEWSKI, T1
Carobrez, Ade P1
Bergink, V; van Megen, HJ; Westenberg, HG1
Arnold, PD; Richter, MA; Zai, G1
Barenbaum, RD; Rilla Manta, L1
Cortese, BM; Fitzgerald, DA; Moore, GJ; Phan, KL; Seraji-Bozorgzad, N; Tancer, ME1
Bennett, M; Mancini, C; Patterson, B; Van Ameringen, M1
Cortese, BM; Phan, KL1
Gillespie, CF; Ressler, KJ1
Gorman, JM; Simon, AB1
Benjamini, Y; Elmer, GI; Frank, BC; Kafkafi, N; Lee, NH; Letwin, NE; Luu, T; Mayo, C1
Chen, CP; Cummings, JL; Lai, MK; Tsang, SW; Vinters, HV; Wong, PT1
Amiel, JM; Mathew, SJ1
Guo, JD; Mania, I; Muly, EC; Rainnie, DG1
Jensen, JE; Kaufman, RE; Pollack, MH; Renshaw, PF; Simon, NM1
Mineur, YS; Picciotto, MR; Vieyra-Reyes, P1
Howells, FM; Russell, VA1

Reviews

12 review(s) available for glutamic acid and Anxiety Disorders

ArticleYear
Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients.
    Current topics in medicinal chemistry, 2020, Volume: 20, Issue:9

    Topics: Alcoholism; Anxiety Disorders; Brain; Comorbidity; Cytokines; Depressive Disorder, Major; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Imaging; Neuroimaging; Neuropsychological Tests; Neurotransmitter Agents; Severity of Illness Index

2020
The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Glutamic Acid; Humans; Receptors, Metabotropic Glutamate

2014
Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction.
    Annals of the New York Academy of Sciences, 2008, Volume: 1141

    Topics: Alcoholism; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; CHO Cells; Cricetinae; Cricetulus; Depressive Disorder; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mice; Mice, Knockout; Protein Conformation; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Smoking; Structure-Activity Relationship; Substance-Related Disorders

2008
Advances in pharmacotherapy for pediatric anxiety disorders.
    Depression and anxiety, 2011, Volume: 28, Issue:1

    Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Brain; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Evidence-Based Medicine; Female; Glutamic Acid; Humans; Male; Obsessive-Compulsive Disorder; Phobic Disorders; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors

2011
The role of GABA in anxiety disorders.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 3

    Topics: Acetates; Amines; Anxiety Disorders; Benzodiazepines; Cyclohexanecarboxylic Acids; GABA Agents; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Nipecotic Acids; Receptors, GABA-A; Synaptic Transmission; Tiagabine

2003
[Glutamatergic neurotransmission as molecular target in anxiety].
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2003, Volume: 25 Suppl 2

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Periaqueductal Gray

2003
Glutamate and anxiety.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:3

    Topics: Animals; Anxiety; Anxiety Disorders; Disease Models, Animal; Glutamic Acid; Humans; Neurobiology; Receptors, Glutamate

2004
Genetics of anxiety disorders.
    Current psychiatry reports, 2004, Volume: 6, Issue:4

    Topics: Anxiety Disorders; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Child; Cholecystokinin; Gene Expression; Genetic Linkage; Glutamic Acid; Humans; Inhibition, Psychological; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Biology; Nerve Tissue Proteins; Neurotic Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Phenotype; Point Mutation; Serotonin; Serotonin Plasma Membrane Transport Proteins

2004
The role of glutamate in anxiety and related disorders.
    CNS spectrums, 2005, Volume: 10, Issue:10

    Topics: Animals; Anticonvulsants; Anxiety Disorders; Arousal; Brain; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fear; Glutamic Acid; Humans; Magnetic Resonance Imaging

2005
Emotional learning and glutamate: translational perspectives.
    CNS spectrums, 2005, Volume: 10, Issue:10

    Topics: Animals; Anxiety Disorders; Behavior Therapy; Brain; Cycloserine; Disease Models, Animal; Emotions; Extinction, Psychological; Fear; Glutamic Acid; Humans; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Rodentia

2005
Advances in the treatment of anxiety: targeting glutamate.
    NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2006, Volume: 3, Issue:1

    Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Glutamic Acid; Humans; Receptors, Metabotropic Glutamate; Stress, Psychological

2006
Glutamate and anxiety disorders.
    Current psychiatry reports, 2007, Volume: 9, Issue:4

    Topics: Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Brain; Double-Blind Method; Excitatory Amino Acid Agents; Glutamic Acid; Humans; Randomized Controlled Trials as Topic; Receptors, AMPA; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate

2007

Trials

2 trial(s) available for glutamic acid and Anxiety Disorders

ArticleYear
Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.
    Neuroscience letters, 2012, Nov-14, Volume: 530, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Aspartic Acid; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Occipital Lobe; Pilot Projects; Riluzole; Treatment Outcome

2012
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Apr-01, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levetiracetam; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nootropic Agents; Piracetam

2008

Other Studies

27 other study(ies) available for glutamic acid and Anxiety Disorders

ArticleYear
Thin graphene oxide nanoflakes modulate glutamatergic synapses in the amygdala cultured circuits: Exploiting synaptic approaches to anxiety disorders.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 26

    Topics: Amygdala; Animals; Anxiety Disorders; Glutamic Acid; Graphite; Humans; Nanostructures; Neurons; Patch-Clamp Techniques; Rats; Synapses; Synaptic Transmission

2020
Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.
    Molecular psychiatry, 2020, Volume: 25, Issue:3

    Topics: Adult; Amygdala; Anxiety; Anxiety Disorders; Biomarkers; Fear; Female; Glutamic Acid; Hippocampus; Humans; Long-Term Potentiation; Male; Neuronal Plasticity; Phosphorylation; Receptors, AMPA; Receptors, Glutamate; Seizures; Serine; Synaptic Transmission

2020
Nitrergic signaling modulation by ascorbic acid treatment is responsible for anxiolysis in mouse model of anxiety.
    Behavioural brain research, 2019, 05-17, Volume: 364

    Topics: Affect; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Ascorbic Acid; Behavior, Animal; Brain; Disease Models, Animal; Glutamic Acid; Male; Maze Learning; Mice; Motor Activity; Nitrates; Nitrergic Neurons; Nitric Oxide; Signal Transduction

2019
Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy.
    Translational psychiatry, 2019, 06-18, Volume: 9, Issue:1

    Topics: Adult; Anxiety Disorders; Cross-Sectional Studies; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Male; Neuroticism; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Young Adult

2019
A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder.
    Neuropsychobiology, 2013, Volume: 67, Issue:4

    Topics: Adolescent; Anxiety Disorders; Aspartic Acid; Brain Chemistry; Case-Control Studies; Child; Creatine; Female; Glutamic Acid; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Pilot Projects

2013
Reward memory relieves anxiety-related behavior through synaptic strengthening and protein kinase C in dentate gyrus.
    Hippocampus, 2016, Volume: 26, Issue:4

    Topics: Animals; Anxiety Disorders; Benzophenanthridines; Dendritic Spines; Dentate Gyrus; Disease Models, Animal; Excitatory Postsynaptic Potentials; Glutamic Acid; Long-Term Potentiation; Male; Maze Learning; Memory; Mice, Inbred DBA; Protein Kinase C; Protein Kinase Inhibitors; Reward; Synapses; Up-Regulation

2016
Effects of paternal and peripubertal stress on aggression, anxiety, and metabolic alterations in the lateral septum.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:2

    Topics: Age Factors; Aggression; Animals; Animals, Newborn; Anxiety Disorders; Aspartic Acid; Creatine; Disease Models, Animal; Female; Glutamate Decarboxylase; Glutamic Acid; Magnetic Resonance Spectroscopy; Male; Maze Learning; Phosphorylcholine; Rats; Rats, Wistar; Septal Nuclei; Stress, Psychological; Tritium

2016
Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.
    Molecular psychiatry, 2017, Volume: 22, Issue:3

    Topics: Amygdala; Animals; Anxiety; Anxiety Disorders; Basolateral Nuclear Complex; Corticosterone; Excitatory Amino Acid Agents; Fear; GABA Agents; GABAergic Neurons; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamo-Hypophyseal System; Mice; Mice, Knockout; Neurons; Pituitary-Adrenal System; Prosencephalon; Receptors, Glucocorticoid; Receptors, Glutamate; Synaptic Transmission

2017
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:12

    Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles

2008
A role for LYNX2 in anxiety-related behavior.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Mar-17, Volume: 106, Issue:11

    Topics: Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Glutamic Acid; Membrane Glycoproteins; Mice; Mice, Mutant Strains; Neuropeptides; Protein Binding; Receptors, Nicotinic; Synaptic Transmission

2009
Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
    Metabolic brain disease, 2009, Volume: 24, Issue:4

    Topics: Action Potentials; Animals; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Glutamic Acid; Male; Methylphenidate; Neurons; Presynaptic Terminals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Substantia Nigra; Synaptic Transmission; Up-Regulation; Ventral Tegmental Area

2009
Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy.
    The American journal of psychiatry, 2010, Volume: 167, Issue:10

    Topics: Acute Disease; Adult; Animals; Anxiety; Anxiety Disorders; Aspartic Acid; Choline; Diagnostic and Statistical Manual of Mental Disorders; Down-Regulation; Electroshock; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Psychiatric Status Rating Scales; Stress, Psychological; Synaptic Transmission

2010
The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
    Neurobiology of learning and memory, 2010, Volume: 94, Issue:4

    Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Drug Interactions; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Midazolam; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric

2010
Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in mice.
    Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Chlordiazepoxide; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Receptors, N-Methyl-D-Aspartate

2011
Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways.
    Molecular & cellular proteomics : MCP, 2011, Volume: 10, Issue:12

    Topics: Amino Acid Sequence; Animals; Anxiety Disorders; Biomarkers; Carbonic Anhydrase II; Glutamic Acid; Hippocampus; Inositol; Lactoylglutathione Lyase; Male; Metabolic Networks and Pathways; Metabolomics; Molecular Sequence Data; Multifactorial Inheritance; Peptide Fragments; Prealbumin; Protein Array Analysis; Proteomics; Serum Amyloid P-Component

2011
Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu₅): from an artificial neural network virtual screen to an in vivo tool compound.
    ChemMedChem, 2012, Mar-05, Volume: 7, Issue:3

    Topics: Allosteric Regulation; Animals; Anxiety Disorders; Behavior, Animal; Benzoxazoles; Brain; Drug Discovery; Glutamic Acid; HEK293 Cells; High-Throughput Screening Assays; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Neural Networks, Computer; Psychotropic Drugs; Pyrimidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; ROC Curve; Small Molecule Libraries

2012
Structure-activity relationships for negative allosteric mGluR5 modulators.
    ChemMedChem, 2012, Mar-05, Volume: 7, Issue:3

    Topics: Alkynes; Allosteric Regulation; Amino Acid Sequence; Animals; Anti-Anxiety Agents; Anxiety Disorders; Binding Sites; Brain; CHO Cells; Cricetinae; Dimerization; Glutamic Acid; Humans; Models, Molecular; Molecular Sequence Data; Protein Binding; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Structure-Activity Relationship

2012
Psychiatric drugs. Excited by glutamate.
    Science (New York, N.Y.), 2003, Jun-20, Volume: 300, Issue:5627

    Topics: Animals; Anxiety Disorders; Brain; Brain Diseases; Bridged Bicyclo Compounds; Clinical Trials as Topic; Depressive Disorder; Dopamine; Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Neurons; Pain; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders; Synaptic Transmission

2003
[Selected cases from practical neurology; painful muscle spasm, anxiety conditions, and glutamic acid].
    Wiadomosci lekarskie (Warsaw, Poland : 1948), 1955, Volume: 8, Issue:1

    Topics: Anxiety; Anxiety Disorders; Glutamates; Glutamic Acid; Humans; Muscle Cramp; Nervous System Diseases; Neurology; Neurotic Disorders; Pain; Spasm

1955
[New molecular targets in pharmacological treatment of anxiety disorders].
    Vertex (Buenos Aires, Argentina), 2004, Volume: 15 Suppl 1

    Topics: Anxiety Disorders; Benzodiazepines; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Molecular Biology; Nipecotic Acids; Pregabalin; Receptors, GABA; Tiagabine

2004
Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla.
    Neuroreport, 2005, Feb-08, Volume: 16, Issue:2

    Topics: Anxiety Disorders; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Occipital Lobe; Protons; Social Behavior

2005
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
    Depression and anxiety, 2006, Volume: 23, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Caudate Nucleus; Drug Resistance; Drug Synergism; Female; Fructose; Glutamic Acid; Humans; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Topiramate

2006
Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene-behavior associations.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, May-17, Volume: 26, Issue:20

    Topics: Alcoholism; Animals; Anxiety Disorders; Behavior, Animal; Brain; Brain Chemistry; Brain Mapping; Chromosome Mapping; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Genetics, Behavioral; Genomics; Glutamic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Phenotype; Signal Transduction; Species Specificity

2006
Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.
    Neurobiology of aging, 2008, Volume: 29, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Binding, Competitive; Brain; Chronic Disease; Female; Glutamic Acid; Glycine; Humans; Ligands; Male; Neocortex; Neurons; Neuropsychological Tests; Protein Binding; Protein Subunits; Radioligand Assay; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate

2008
Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution.
    The Journal of comparative neurology, 2007, Dec-20, Volume: 505, Issue:6

    Topics: Amygdala; Animals; Anxiety Disorders; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Membrane Potentials; Microscopy, Immunoelectron; Neural Inhibition; Neural Pathways; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channels; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Septal Nuclei; Synaptic Transmission

2007
Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors.
    Neuroscience letters, 2008, Mar-21, Volume: 434, Issue:1

    Topics: Administration, Oral; Animals; Anxiety Disorders; Behavior, Animal; Brain; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Down-Regulation; Glutamic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motor Activity; Neural Pathways; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Receptors, AMPA; Reward; Synaptic Transmission; Tobacco Use Disorder; Ventral Tegmental Area; Volition

2008
Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Brain research, 2008, Mar-20, Volume: 1200

    Topics: Animals; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Disease Models, Animal; Endocytosis; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; N-Methylaspartate; Norepinephrine; Organ Culture Techniques; Presynaptic Terminals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Species Specificity; Synaptic Transmission

2008